Clinical Trials on Allogeneic Hematopoietic Stem Cell Transplantation

Total 1289 results

Catholic University of the Sacred Heart
Pagano L, Aversa F, Locatelli F, Nosari A,Rossi G, Viale P

Completed

A Prospective Registry for Febrile Events in Patients With Malignant Hemopathies or Subjected to Haematopoietic Stem Cell Transplant (HEMA E-CHART)

Stem Cell Transplantation | Hematological Malignancies

Italy
Radboud University Medical Center

Enrolling by invitation

Oral Complications After Haematopoietic Stem Cell Transplantation: a Retrospective Study (RadboudStem)

Stem Cell Transplant Complications | Oral Complication

Netherlands
University of Colorado, Denver
GlaxoSmithKline

Recruiting

Shingrix In Recipients of Allogeneic Transplants (Allo)

Stem Cell Transplant | Bone Marrow Transplant

United States
King Faisal Specialist Hospital and Research Centre...

Completed

Change in Management Following Bronchoscopy in Hematopoietic Stem Cell Transplant Patients With Pulmonary Infiltrates

Pulmonary Complication | Stem Cell Transplant Complications

Saudi Arabia
Azienda Ospedaliera San Giovanni Battista

Completed

Allogeneic Bone Marrow Transplantation From Unrelated Donors in Multiple Myeloma (MM2011)

Multiple Myeloma | Allogeneic Transplantation

Italy
University of California, San Francisco
Lazarex Cancer Foundation

Terminated

Impact of Phone Call About Financial Reimbursement Program on Access to Cancer Clinical Trials

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Neoplasm

United States
Chin-Hung Chang

Available

Cartilage Tissue Engineering

Mesenchymal Stem Cells
Instituto Brasileiro de Controle do Cancer

Not yet recruiting

Efficacy of N-acetylcysteine Versus Placebo as Prophylaxis of Sinusoidal Obstruction Syndrome in Patients Undergoing Hematopoietic Stem Cell Transplantation (ALISON)

Hematopoietic Stem Cell Transplant (HSCT) | Sinusoidal Obstruction Syndrome (SOS)

Brazil
Assistance Publique - Hôpitaux de Paris
Institut National de la Santé Et de la Recherche Médicale, France; Institut... and other collaborators

Completed

Ontogeny of MAIT Cells in Neonates and Hematopoietic Stem Cell Transplant Recipients (NEOMAIT)

Term and Preterm Neonates (24-41 Weeks Gestational Age) | Hematopoietic Stem Cell Transplant Recipient Children

France
Holostem Terapie Avanzate s.r.l.
Cromsource

Completed

Follow-up Study After ACLSCT for Restoration of Corneal Epithelium in Patients With LSCD Due to Ocular Burns (HOLOCORE-FU)

Limbal Stem Cell Deficiency Due to Ocular Burn

Italy
University of Aarhus

Completed

Adipose-tissue Derived Stem Cells in Flaps Versus Liposuction

Mesenchymal Stem Cells
Ning Huang

Not yet recruiting

A Clinical Study of Autologous Peripheral Blood Stem Cell Mobilization for PEG-G-CSF

Granulocyte Colony-stimulating Factor | Stem Cell Mobilization
Memorial Sloan Kettering Cancer Center

Completed

A Study to Assess Thymic Function Using PET/CT and MRI

CD34 Selected Peripheral Blood Stem Cell Graft

United States
Sun Yat-sen University

Unknown

Allogene MSCs Transplantation in Patients With Chronic Liver Diseases Through Peripheral Vein.

Allogene MSCs Transplantation | Chronic Liver Diseases Patients | Peripheral Vein

China
Mayo Clinic

Completed

Use of Sublingual Tacrolimus in Adult Blood and Marrow Transplant Patients

Stem Cell Transplant | Immunosuppression | Bone Marrow Transplant

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Ixazomib Citrate and Lenalidomide After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma

Plasma Cell Myeloma | Hematopoietic Cell Transplantation Recipient

United States
Micah Skeens
National Institute of Nursing Research (NINR)

Recruiting

BMT4me: Post-HSCT Medication Adherence mHealth App (Bmt4me 2)

Adherence, Medication | Stem Cell Transplant | Digital Health

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI); Oregon Health and Science University

Recruiting

Predicting the Impact of Treatment Toxicities on Health During Cancer (PATTERN)

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm

United States
Mayo Clinic

Recruiting

Role of Gut Microbiome in Cancer Therapy

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm

United States
M.D. Anderson Cancer Center

Recruiting

Complications and Clinical Response in Cancer Patients Treated With Anti-VEGF-Related Therapies

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm

United States
Mayo Clinic
National Cancer Institute (NCI)

Recruiting

Understanding the Challenges, Behavioral Patterns, and Preferences Towards Participation in Clinical Trials in Minority Patient Populations for the Development of a Personalized Clinical Trial Educational Platform to Increase Participation in Clinical Trials Among Underserved Cancer Patients

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Preliminary Testing of the MD Anderson Symptom Inventory (Adolescent Version)

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm

United States
Ohio State University Comprehensive Cancer Center

Active, not recruiting

An Educational Intervention on Provider Knowledge for the Support of Cancer Survivors

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Telementoring Intervention (ECHO) for the Transformation of Professional Engagement, Practice Efficiency, and Community Building Through Team Meetings in Diagnostic Imaging Clinicians

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm

United States
M.D. Anderson Cancer Center

Withdrawn

Palliative, Rehabilitation, and Integrated Medicine Handbook for Self Care at Work

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

New Magnetic Resonance Imaging and Spectroscopy Software in the Improvement of Image Quality

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm

United States
Thomas Jefferson University

Completed

Geriatric Assessment Screening Tool for the Identification of At-Risk Older Adults Who Are Undergoing Cancer Treatment

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm

United States
M.D. Anderson Cancer Center

Completed

Evaluation of Satisfaction With Quality of Care on the Palliative Care Unit

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Elotuzumab and Lenalidomide After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma

Plasma Cell Myeloma | Hematopoietic Cell Transplantation Recipient

United States
Johann Wolfgang Goethe University Hospital

Completed

Progenitor Cell Therapy in Dilative Cardiomyopathy

Stem Cell Transplantation | Cardiomyopathy, Dilated | Heart Failure, Congestive
Institute of Cardiometabolism and Nutrition, France

Enrolling by invitation

Developing Derived Induced Pluripotent Stem Cells as a Model to Understand Imprinted Disorders (ID-STEM)

Induced Pluripotent Stem Cells

France
Ankara University

Unknown

Placental Transfusion Methods and Stem Cells

Placental Transfusion | Stem Cells
National Institutes of Health Clinical Center (CC)

Withdrawn

Blood Collection From Healthy Volunteers and Patients for the Production of Clinical Grade Induced Pluripotent Stem Cell (iPSC) Products

Induced Pluripotent Stem Cells
Rambam Health Care Campus

Unknown

Generation of Haploid Stem Cells From Human Germ Cells

Induced Pluripotent Stem Cells

Israel
Asan Medical Center
MIRAE CELL BIO

Unknown

Safety of Human Embryonic Stem Cell (hESC)-Derived Mesenchymal Stem Cells in Interstitial Cystitis

Stem Cell Transplant | Interstitial Cystitis | Mesenchymal Stem Cell

Korea, Republic of
Chang Gung Memorial Hospital

Recruiting

Cultivated Autologous Oral Mucosal Epithelial Transplantation

Limbal Stem Cell Deficiency

Taiwan
Instituto de Oftalmología Fundación Conde de Valenciana
National Council of Science and Technology, Mexico

Terminated

ABCB5 as a Prognostic Marker in Survival of Cultivated Limbal Stem Cell Transplantation

Limbal Stem Cell Deficiency

Mexico
Tel-Aviv Sourasky Medical Center

Unknown

COVID-19 Vaccine in Patients After Allogeneic HCT, CAR-T Therapy and With Primary Immune Deficiency

Primary Immunodeficiency | Allogenic Hematopoietic Cell Transplant | CAR-T Therapy

Israel
Ethisch Comité UZA
University Hospital, Ghent; Universitair Ziekenhuis Brussel

Unknown

Limbal Epithelial Stem Cell Transplantation: a Phase II Multicenter Trial (MLEC)

Limbal Stem Cell Deficiency

Belgium
M.D. Anderson Cancer Center

Recruiting

Survey Assessment of Patient and Provider Impressions of Telemedicine in Radiation Oncology

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm

United States
University of Rochester NCORP Research Base
National Cancer Institute (NCI); Roswell Park Cancer Institute

Recruiting

An Observational Research Study for Cancer Patients on Immune Checkpoint Inhibitors, DiRECT Study (DiRECT)

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm

United States
Roswell Park Cancer Institute

Recruiting

Yoga Intervention for the Improvement of Cancer-Related Stress in Cancer Survivors

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm

United States
Children's Oncology Group
National Cancer Institute (NCI); MedStar Georgetown University Hospital

Active, not recruiting

Mobile Health and Social Media Physical Activity Intervention Among Adolescent and Young Adult Childhood Cancer Survivors, the StepByStep Study

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm

United States, Canada
M.D. Anderson Cancer Center

Active, not recruiting

Parental Attitudes and Beliefs Regarding Risks Associated With Opioid Use in Children With Cancer

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm

United States
Thomas Jefferson University

Completed

Measuring the Impact of MANNA s Medically Tailored Meal Program in Patients With a Non-terminal Cancer Diagnosis

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Perioperative Care in the Cancer Patient -1, ARCA-1 Study

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Enrolling by invitation

Testing Counseling and Mobile Health Interventions to Improve Physical Activity and Diet Quality in Survivors of Childhood Cancer (SALSA)

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm

United States
Thomas Jefferson University

Completed

Development of the Oncology Opportunity Cost Assessment Tool

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm

United States
University of California, San Francisco
Akili Interactive Labs, Inc.

Completed

Study of Attention and Memory Treatments for Cancer Survivors

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm

United States
National Cancer Institute (NCI)

Completed

Azacitidine and Oxaliplatin In Treating Patients With Advanced Cancers Relapsed or Refractory to Any Platinum Therapy

Hematopoietic and Lymphoid Cell Neoplasm | Adult Solid Neoplasm

United States

Clinical Trials on Allogeneic Hematopoietic Stem Cell Transplantation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Morocco

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations